Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis

Published:2022-11 Issue: Volume:179 Page:103801
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Fallara Giuseppe,Belladelli Federico,Robesti Daniele,Raggi Daniele,Nocera Luigi,Marandino Laura,Galsky Matthew D.,Montorsi Francesco,Malavaud Bernard,Ploussard Guillaume,Necchi Andrea,Martini Alberto

Funder

Ipsen

AstraZeneca

Merck

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference46 articles.

1. Assessment of study quality for systematic reviews: a comparison of the cochrane collaboration risk of bias tool and the effective public health practice project quality assessment tool: methodological research;Armijo-Olivo;J. Eval. Clin. Pr.,2012

2. Five-year survival prediction and safety outcomes with enzalutamide in men with chemotherapy-naïve metastatic castration-resistant prostate cancer from the PREVAIL trial;Armstrong;Eur. Urol.,2020

3. Enzalutamide in men with chemotherapy-naïve metastatic castration-resistant prostate cancer: extended analysis of the phase 3 PREVAIL study;Beer;Eur. Urol.,2017

4. The association between testosterone, estradiol and their ratio and mortality among US men;Belladelli;Andrologia,2021

5. Subsequent chemotherapy and treatment patterns after abiraterone acetate in patients with metastatic castration-resistant prostate cancer: post hoc analysis of COU-AA-302;de Bono;Eur. Urol.,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in second-line treatment: a systematic review and bayesian network meta-analysis;BMC Cancer;2024-06-08

2. Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review;Cancers;2023-07-03